Total Payments
$3,021
2024 Payments
$1,158
Companies
28
Transactions
158
Medicare Patients
3,989
Medicare Billing
$361,367
Payment Breakdown by Category
Food & Beverage$3,021 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,021 | 158 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $640.18 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $366.37 | 16 | $0 (2024) |
| Novo Nordisk Inc | $318.68 | 19 | $0 (2024) |
| Lilly USA, LLC | $299.79 | 18 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $189.91 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $155.84 | 10 | $0 (2024) |
| Amgen Inc. | $154.62 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $93.68 | 5 | $0 (2024) |
| Abbott Laboratories | $91.52 | 5 | $0 (2024) |
| PFIZER INC. | $87.83 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,158 | 59 | ABBVIE INC. ($258.40) |
| 2023 | $1,276 | 68 | ABBVIE INC. ($291.05) |
| 2022 | $537.34 | 30 | Novo Nordisk Inc ($125.86) |
| 2019 | $50.00 | 1 | Janssen Pharmaceuticals, Inc ($50.00) |
All Payment Transactions
158 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: VACCINES | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: ANTIBIOTIC | ||||||
| 10/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Cardio-renal | ||||||
| 10/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.86 | General |
| Category: DIABETES | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Oncology | ||||||
| 09/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Diabetes | ||||||
| 09/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: PAIN | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Neurology | ||||||
| 08/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,030 | 1,625 | $309,298 | $107,605 |
| 2022 | 10 | 914 | 1,415 | $286,185 | $98,471 |
| 2021 | 11 | 900 | 1,368 | $238,784 | $86,799 |
| 2020 | 14 | 1,145 | 1,555 | $229,678 | $68,491 |
Total Patients
3,989
Total Services
5,963
Medicare Billing
$361,367
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 306 | 661 | $163,267 | $48,529 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 245 | 245 | $61,495 | $29,376 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 178 | 320 | $55,680 | $17,927 | 32.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 38 | 39 | $7,032 | $2,957 | 42.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $5,848 | $2,620 | 44.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 15 | $5,835 | $2,109 | 36.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 109 | 189 | $4,536 | $1,791 | 39.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 49 | $1,960 | $1,405 | 71.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 23 | 27 | $1,674 | $399.12 | 23.8% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 14 | 15 | $780.00 | $227.59 | 29.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 19 | $988.00 | $166.08 | 16.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 29 | $203.00 | $98.89 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 301 | 698 | $172,406 | $50,731 | 29.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 206 | 206 | $51,706 | $25,346 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 211 | $36,714 | $11,690 | 31.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 56 | 56 | $10,640 | $3,914 | 36.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 22 | 22 | $7,568 | $3,465 | 45.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 63 | 63 | $2,016 | $1,712 | 84.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 64 | 86 | $2,064 | $812.20 | 39.4% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 28 | 35 | $2,170 | $446.74 | 20.6% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 13 | 13 | $726.00 | $268.18 | 36.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 23 | 25 | $175.00 | $85.52 | 48.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 294 | 705 | $166,212 | $57,134 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 116 | 116 | $28,881 | $14,530 | 50.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 118 | $19,264 | $6,577 | 34.1% |
About Dr. Timothy Moser, D.O
Dr. Timothy Moser, D.O is a Family Medicine healthcare provider based in Midwest City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790777035.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Moser, D.O has received a total of $3,021 in payments from pharmaceutical and medical device companies, with $1,158 received in 2024. These payments were reported across 158 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,021).
As a Medicare-enrolled provider, Moser has provided services to 3,989 Medicare beneficiaries, totaling 5,963 services with total Medicare billing of $361,367. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Midwest City, OK
- Active Since 08/22/2005
- Last Updated 04/20/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1790777035
Products in Payments
- QULIPTA (Drug) $226.13
- VRAYLAR (Drug) $192.25
- UBRELVY (Drug) $190.73
- Kerendia (Drug) $189.91
- JARDIANCE (Drug) $176.22
- Ozempic (Drug) $171.22
- AIRSUPRA (Drug) $155.50
- TRELEGY ELLIPTA (Drug) $121.37
- FARXIGA (Drug) $115.28
- Rybelsus (Drug) $113.72
- TRULICITY (Drug) $113.04
- BREZTRI (Drug) $95.59
- FREESTYLE LIBRE 3 (Device) $91.52
- Otezla (Drug) $80.34
- EVENITY (Biological) $74.28
- MOUNJARO (Drug) $73.51
- APLENZIN (Drug) $68.21
- TRINTELLIX (Drug) $65.87
- Dexcom G6 Transmitter (Medical Supply) $53.00
- NURTEC ODT (Drug) $51.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Midwest City
Dr. Zeming Deng, M.d, M.D
Family Medicine — Payments: $15,411
Family Medicine $15,411
Aubrey Kavanaugh, M.d, M.D
Family Medicine — Payments: $15,125
Family Medicine $15,125
Melvin Cook, Md, MD
Family Medicine — Payments: $13,195
Family Medicine $13,195
Dr. Michael Anderson, Md, MD
Family Medicine — Payments: $12,118
Family Medicine $12,118
Tanner Mcdaniel, Md, MD
Family Medicine — Payments: $11,976
Family Medicine $11,976
Dr. Joshua Smith, M.d, M.D
Family Medicine — Payments: $10,425
Family Medicine $10,425